← Back to IGF-1 LR3

VS Peps · Certificate № JN-260526-7450

Certificate of Analysis

Compound identity

IGF

IGF-1 LR3

Long-R3 IGF-1 analog · 1mg lyophilized

Batch identifiers

Batch IDJN-260526-7450
Lab referenceLR-96650
Test date2026-05-26
Format1mg · lyophilized

HPLC Analysis

High-Performance Liquid Chromatography

Reported purity

99.0%

Area under the target peak as a percentage of total area.

Batch · 2026-05-26Janoshik Analytical · HPLC
99.0%IGF2 MIN5 MIN8 MIN12 MIN

Identity verification

Compound nameIGF-1 LR3
Editorial codeIGF
Molecular formConfirmed by MS
Test methodRP-HPLC / UV-Vis
Reference standardIn-house standard, characterized
Storage at testLyophilized, sealed vial, RT

Structure

83residues
3-letter notation

83-residue peptide. Full sequence elided for readability — downloadable on the certificate of analysis.

Modifications

  • 01Arg substitution at position 3
  • 0213-residue N-terminal extension
  • 03Resistance to IGFBP binding

Sourcing & storage

Sourcing chain

Manufactured in a GMP-audited facility (cGMP-compliant)

Storage & handling

Lyophilized: stable at room temperature in original sealed vial. Reconstituted: refrigerate at 2–8°C and use within 21 days. Research use only.

Lab analyst signature

Janoshik Analytical

Verified · 2026-05-26

Document control

Certificate № JN-260526-7450Issued 2026-05-26Format RP-HPLC / UVDistribution Per-product page

Research use only. This certificate documents analytical results for the batch identified above. Products are sold strictly for laboratory and research applications and are not intended for human or animal consumption, diagnosis, treatment, or prevention of any disease. The information herein is provided in good faith based on third-party HPLC analysis but is not a guarantee or warranty. See Research Use Disclaimer for full terms.